Abbott Laboratories ABT

NYSE US Health Care

$105.70 ▲ +0.09% (+$0.09)

Index member: S&P 500

Open $104.46

Prev Close $105.61

Day Range $102.89 – $106.39

52W Range $81.97 – $137.49

Market Cap $186.84B

P/E (TTM) 33.66

Beta 0.58

Div Yield 2.39%

EPS (TTM) $3.11

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	1937-03-01
Shares Out.	1,741,810,000
Website	abbott.com ↗
Phone	12246676100
Employees	115,000
Revenue	$12.59B
Gross Profit	$7.27B
Net Income	$928.0M
Free Cash Flow	$7.82B
Total Assets	$109.22B
Total Liabilities	$57.45B
Equity	$51.76B

About Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Abbott Laboratories is a publicly traded company under the ticker symbol ABT on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.